Related Experiment Video
Updated: Jan 19, 2026

07:08
Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
1.4K
Pancreatic Cancer Incidence, Mortality, and Survival in Puerto Rico, 2001-2015.
M Castañeda-Avila1, C R Torres-Cintrón2, A Cruz-Benítez1
1Department of Biostatistics and Epidemiology, Graduate School of Public Health, University of Puerto Rico Medical Sciences Campus, San Juan, PR.
Puerto Rico Health Sciences Journal
|September 20, 2019
Summary
Pancreatic cancer (PC) incidence and mortality are increasing in Puerto Rico, with lower rates than in some US groups but poor survival. Further research into treatment access and response is crucial.
Area of Science:
- Epidemiology
- Oncology
- Public Health
Background:
- Pancreatic cancer (PC) poses a significant health challenge globally.
- Understanding the epidemiological profile of PC in specific populations is vital for targeted interventions.
- Puerto Rico (PR) has unique demographic and healthcare factors that may influence PC trends.
Purpose of the Study:
- To establish an epidemiological profile of pancreatic cancer in Puerto Rico.
- To analyze incidence, mortality, and survival trends of PC in PR from 2001 to 2015.
- To compare PC rates in PR with those in the United States Hispanic, non-Hispanic white, and non-Hispanic black populations.
Main Methods:
- Utilized data from the Puerto Rico Central Cancer Registry (PRCCR).
- Estimated incidence and mortality rates and trends for PC in PR.
- Conducted survival analyses and comparative analyses with US racial/ethnic groups.
Main Results:
- PC incidence was 7.8 per 100,000 and mortality was 6.7 per 100,000 in PR (2011-2015).
- Higher rates were observed in men and individuals aged 65+.
- Incidence and mortality trends showed increases (APC 3.8% and 1.9%, respectively) from 2001-2015; median survival was 5.3 months.
Conclusions:
- Puerto Rico exhibits increasing PC mortality rates and notably low patient survival.
- PC incidence and mortality rates in PR were lower compared to certain racial/ethnic groups in the US.
- Further investigation into treatment access and response is recommended to mitigate PC burden and improve survival in PR.
Related Concept Videos
Cancer Survival Analysis
650
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
650
Prevalence and Incidence
1.5K
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.5K

